| Ian Myers, MD | |
|
2600 Glasgow Ave, Suite 126, Newark, DE 19702-4773 | |
| (302) 832-7600 | |
| Not Available |
| Full Name | Ian Myers |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 2600 Glasgow Ave, Newark, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194783019 | NPI | - | NPPES |
| P00070381 | Other | DE | MEDICARE RAILROAD |
| 758403200 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | C1-0005890 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christiana Hospital | Newark, DE | Hospital |
| Union Hospital Of Cecil County | Elkton, MD | Hospital |
| Mercy Health - West Hospital | Cincinnati, OH | Hospital |
| Entity Name | Ian Myers, Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578596649 PECOS PAC ID: 6709942311 Enrollment ID: O20090306000119 |
News Archive
Chelsea Therapeutics International, Ltd. announced that during a teleconference yesterday, the U.S. Food and Drug Administration requested that the company delay the initiation of its proposed Phase II clinical study of CH-4051 in rheumatoid arthritis and indicated that the agency is requesting additional detail from the preclinical studies previously submitted as part of the company's investigational new drug application.
It's a paradox of Alzheimer's disease: Plaques of the sticky protein amyloid beta are the most characteristic sign in the brain of the deadly neurodegenerative disease. However, many older people have such plaques in their brains but do not have dementia.
An international team of researchers, led by the University of Granada, has taken a significant step forward on the research on 'genetic sex reprogramming', which is closer now, although it's still an utopia.
One in 25,000 people worldwide is affected by neurofibromatosis type 2 (NF2), a condition where the loss of a tumour suppressor called Merlin results in multiple tumours in the brain and nervous system.
With a push to make hospitals and doctors more accountable for health care quality, more attention must be paid to the accuracy and reliability of measures used to evaluate caregivers, says a prominent Johns Hopkins patient safety expert.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ian Myers, MD 2600 Glasgow Ave Ste 218, Newark, DE 19702-5704 Ph: (302) 832-7600 | Ian Myers, MD 2600 Glasgow Ave, Suite 126, Newark, DE 19702-4773 Ph: (302) 832-7600 |
News Archive
Chelsea Therapeutics International, Ltd. announced that during a teleconference yesterday, the U.S. Food and Drug Administration requested that the company delay the initiation of its proposed Phase II clinical study of CH-4051 in rheumatoid arthritis and indicated that the agency is requesting additional detail from the preclinical studies previously submitted as part of the company's investigational new drug application.
It's a paradox of Alzheimer's disease: Plaques of the sticky protein amyloid beta are the most characteristic sign in the brain of the deadly neurodegenerative disease. However, many older people have such plaques in their brains but do not have dementia.
An international team of researchers, led by the University of Granada, has taken a significant step forward on the research on 'genetic sex reprogramming', which is closer now, although it's still an utopia.
One in 25,000 people worldwide is affected by neurofibromatosis type 2 (NF2), a condition where the loss of a tumour suppressor called Merlin results in multiple tumours in the brain and nervous system.
With a push to make hospitals and doctors more accountable for health care quality, more attention must be paid to the accuracy and reliability of measures used to evaluate caregivers, says a prominent Johns Hopkins patient safety expert.
› Verified 3 days ago
Jarrett Keller Sell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 27 Marrows Rd, Newark, DE 19713 Phone: 302-455-0900 | |
Rabia M Qureshi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Continental Dr, Suite 406, Newark, DE 19713 Phone: 302-368-2630 | |
Angela D Davis Brown, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Glasgow Ave, Suite 124, Newark, DE 19702 Phone: 302-836-4200 Fax: 302-836-8431 | |
David Y Lee, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 | |
Dr. Yoav J Tal, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-623-0188 Fax: 302-733-5640 | |
Joseph James Straight, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4745 Ogletown Stanton Rd Ste 225, Newark, DE 19713 Phone: 302-731-2888 Fax: 302-731-7049 | |
Dr. Judy Mi-young Lim, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 314 E Main St Ste 103, Newark, DE 19711 Phone: 023-663-0550 Fax: 302-366-8905 |